HRT Financial
ZYME icon

HRT Financial’s Zymeworks ZYME Stock Holding History

HRT Financial’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.44M Buy
+167,514
New +$4.34M 0.01% 1358
2026
Q2 		– Sell
-237,889
Closed -$5.96M – 5532
2026
Q1 		$5.96M Buy
237,889
+116,825
+96% +$2.76M 0.01% 897
2025
Q4 		$3.19M Buy
121,064
+52,603
+77% +$1.15M 0.01% 1010
2025
Q3 		$1.17M Buy
68,461
+35,703
+109% +$511K ﹤0.01% 1441
2025
Q2 		$411K Sell
32,758
-32,622
-50% -$389K ﹤0.01% 1698
2025
Q1 		$778K Sell
65,380
-30,594
-32% -$417K ﹤0.01% 1245
2024
Q4 		$1.4M Buy
95,974
+47,166
+97% +$660K 0.01% 901
2024
Q3 		$612K Buy
+48,808
New +$531K ﹤0.01% 1494
2023
Q2 		– Sell
-327,026
Closed -$2.96M – 3416
2023
Q1 		$2.96M Buy
+327,026
New +$2.85M 0.04% 433
2022
Q3 		– Sell
-133,794
Closed -$709K – 3619
2022
Q2 		$709K Buy
+133,794
New +$809K 0.01% 1246

Other funds holding ZYME

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

HRT Financial's ZYME Position: Q3 2026 in Review

HRT Financial opened a new position in Zymeworks (ZYME) in Q3 2026: 167,514 shares worth $4.44M. The stake represents 0.01% of the portfolio and ranks #1358 among its holdings. This is a return to the name: HRT Financial previously reported a position in ZYME as recently as Q1 2026.

HRT Financial first reported a position in ZYME in Q2 2022 and has held it in 10 quarters since. The position peaked at $5.96M in Q1 2026. 144 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

  • HRT Financial held 167,514 shares of Zymeworks worth $4.44M as of Q3 2026.
  • Zymeworks was a new HRT Financial position in Q3 2026.
  • Zymeworks made up 0.01% of HRT Financial's portfolio in Q3 2026, its #1358 holding.
  • HRT Financial first reported a position in Zymeworks in Q2 2022 and has held it in 10 quarters since.
  • HRT Financial's Zymeworks position peaked at $5.96M in Q1 2026.
  • 144 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.